Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1969 1
1975 3
1976 1
1978 2
1979 2
1980 6
1981 9
1982 10
1983 9
1984 2
1985 8
1986 9
1987 15
1988 16
1989 12
1990 15
1991 8
1992 6
1993 11
1994 12
1995 10
1996 11
1997 4
1998 3
1999 8
2000 4
2001 4
2002 8
2003 14
2004 3
2005 6
2006 3
2007 2
2008 10
2009 14
2010 16
2011 22
2012 13
2013 11
2014 14
2015 21
2016 12
2017 9
2018 17
2019 14
2020 12
2021 10
2022 12
2023 7
Text availability
Article attribute
Article type
Publication date

Search Results

422 results
Results by year
Filters applied: . Clear all
Page 1
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Choi J, Manzano A, Dong W, Bellone S, Bonazzoli E, Zammataro L, Yao X, Deshpande A, Zaidi S, Guglielmi A, Gnutti B, Nagarkatti N, Tymon-Rosario JR, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Jeong K, Zhao S, Buza N, Hui P, Ravaggi A, Bignotti E, Romani C, Todeschini P, Zanotti L, Odicino F, Pecorelli S, Ardighieri L, Bilguvar K, Quick CM, Silasi DA, Huang GS, Andikyan V, Clark M, Ratner E, Azodi M, Imielinski M, Schwartz PE, Alexandrov LB, Lifton RP, Schlessinger J, Santin AD. Choi J, et al. Among authors: schwartz pe. Proc Natl Acad Sci U S A. 2021 Apr 13;118(15):e2025182118. doi: 10.1073/pnas.2025182118. Proc Natl Acad Sci U S A. 2021. PMID: 33876771 Free PMC article.
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers SK, Secord AA, Havrilesky L, O'Malley DM, Backes F, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi KS, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Among authors: schwartz pe. J Clin Oncol. 2018 Jul 10;36(20):2044-2051. doi: 10.1200/JCO.2017.76.5966. Epub 2018 Mar 27. J Clin Oncol. 2018. PMID: 29584549 Clinical Trial.
Randomized Phase II Trial of Carboplatin-Paclitaxel Compared with Carboplatin-Paclitaxel-Trastuzumab in Advanced (Stage III-IV) or Recurrent Uterine Serous Carcinomas that Overexpress Her2/Neu (NCT01367002): Updated Overall Survival Analysis.
Fader AN, Roque DM, Siegel E, Buza N, Hui P, Abdelghany O, Chambers S, Secord AA, Havrilesky L, O'Malley DM, Backes FJ, Nevadunsky N, Edraki B, Pikaart D, Lowery W, ElSahwi K, Celano P, Bellone S, Azodi M, Litkouhi B, Ratner E, Silasi DA, Schwartz PE, Santin AD. Fader AN, et al. Among authors: schwartz pe. Clin Cancer Res. 2020 Aug 1;26(15):3928-3935. doi: 10.1158/1078-0432.CCR-20-0953. Epub 2020 Jun 29. Clin Cancer Res. 2020. PMID: 32601075 Free PMC article. Clinical Trial.
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Bellone S, Roque DM, Siegel ER, Buza N, Hui P, Bonazzoli E, Guglielmi A, Zammataro L, Nagarkatti N, Zaidi S, Lee J, Silasi DA, Huang GS, Andikyan V, Damast S, Clark M, Azodi M, Schwartz PE, Tymon-Rosario JR, Harold JA, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Alexandrov LB, Iwasaki A, Kong Y, Song E, Dong W, Elvin JA, Choi J, Santin AD. Bellone S, et al. Among authors: schwartz pe. Cancer. 2022 Mar 15;128(6):1206-1218. doi: 10.1002/cncr.34025. Epub 2021 Dec 7. Cancer. 2022. PMID: 34875107 Free PMC article. Clinical Trial.
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793).
Bellone S, Roque DM, Siegel ER, Buza N, Hui P, Bonazzoli E, Guglielmi A, Zammataro L, Nagarkatti N, Zaidi S, Lee J, Silasi DA, Huang GS, Andikyan V, Damast S, Clark M, Azodi M, Schwartz PE, Tymon-Rosario J, Harold J, Mauricio D, Zeybek B, Menderes G, Altwerger G, Ratner E, Alexandrov LB, Iwasaki A, Kong Y, Song E, Dong W, Elvin J, Choi J, Santin AD. Bellone S, et al. Among authors: schwartz pe. Ann Oncol. 2021 Aug;32(8):1045-1046. doi: 10.1016/j.annonc.2021.04.013. Epub 2021 Apr 28. Ann Oncol. 2021. PMID: 33932502 Free PMC article. Clinical Trial. No abstract available.
Leukemias.
Pejovic T, Schwartz PE. Pejovic T, et al. Among authors: schwartz pe. Clin Obstet Gynecol. 2002 Sep;45(3):866-78. doi: 10.1097/00003081-200209000-00033. Clin Obstet Gynecol. 2002. PMID: 12370628 Review. No abstract available.
In Reply.
Desai VB, Wright JD, Schwartz PE, Gross CP, Xu X. Desai VB, et al. Among authors: schwartz pe. Obstet Gynecol. 2018 Aug;132(2):519-520. doi: 10.1097/AOG.0000000000002770. Obstet Gynecol. 2018. PMID: 30045198 No abstract available.
Review of Leiomyoma Variants.
Arleo EK, Schwartz PE, Hui P, McCarthy S. Arleo EK, et al. Among authors: schwartz pe. AJR Am J Roentgenol. 2015 Oct;205(4):912-21. doi: 10.2214/AJR.14.13946. AJR Am J Roentgenol. 2015. PMID: 26397344 Review.
Reply.
Schwartz PE, Chambers JT, Rutherford TJ, Thiel RP. Schwartz PE, et al. Gynecol Oncol. 1999 Aug;74(2):312-3. doi: 10.1006/gyno.1999.5530. Gynecol Oncol. 1999. PMID: 10419755 No abstract available.
Vulvar ulcers and vulvar carcinoma.
Schwartz PE. Schwartz PE. Menopause. 2011 Oct;18(10):1042-3. doi: 10.1097/gme.0b013e31822a8966. Menopause. 2011. PMID: 22046600 No abstract available.
422 results